Skip to content
Disclosery

MARSHALL WACE, LLP: VRA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on VRA, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 501,404 VRA shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 501,404 shares
    Change vs previous 13F -305,562 shares

    <0.01% of the 13F portfolio, value $1,950,460.

    13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 806,966 shares
    Change vs previous 13F +339,839 shares

    <0.01% of the 13F portfolio, value $2,550,015.

    13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 467,127 shares
    Change vs previous 13F +266,785 shares

    <0.01% of the 13F portfolio, value $1,130,446.

    13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 200,342 shares
    Change vs previous 13F +36,076 shares

    <0.01% of the 13F portfolio, value $402,689.

    13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 164,266 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $363,027.

    13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).